Publications
2023
Back LM, Ladwiniec AH. Saphenous Vein Graft Failure: Current challenges and a review of the contemporary percutaneous options for management. J Clin Med. 2023 Nov 15;12(22):7118.
Kinnaird T, Gallagher S, Farooq V, Protty M, Back LM, Devlin P, Anderson R, Sharp A, Ludman P, Copt S, Mamas MA, Curzen N. Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 to 2017. Circ Cardiovasc Interv. 2023 Jan;16(1):e012350.
2021
Back LM, Hurley S, Beardsley J, Kushwaha V. A case of percutaneous tricuspid valve infective endocarditis vegetation debulking using the AngioJet rheolytic catheter system – a novel therapeutic use. May 2021. Clinical case reports. 2021 Jan;8:213. doi.org/10.23937/2378-2951/1410213.
2020
Back LM, Magdy J, Wong D. Hypertrabeculation with Infiltrative Features across Multiple Imaging Modalities - A Remnant of Prior Cardiac Sarcoid or Primary Noncompaction Cardiomyopathy. Int J Clinical Cardiology. 2020 Dec;7(6). DOI: 10.23937/2378-2951/14102042016
Robaei D, Back LM, Ooi SY, Pitney M, Jepson N. Twelve-Month outcomes with a bioresorbable everolimus eluting scaffold: Results of the ESHC-BVS Registry at two Australian centers. J Invasive Cardiol. 2016 Aug;28(8):316-22.
2015
Back LM, Nagaraja V, Kapur A, Eslick GD. The role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: A meta-analysis of randomized trials. Intern Med J. 2015 Jul;45(7):711-7.
Robaei D, Back LM, Ooi SY, Giles R, Pitney M, Jepson N. Long-term safety of an Everolimus-eluting bioresorbable scaffold: two year clinical outcomes in a wide spectrum of coronary lesions. Heart Lung Circ. 2015 Sep;24(9):854-9.
Presentations
2022
Guiney L, Blake V, Gadley R, Back LM, McGrath J, Yu J, Kushwaha V, Ooi SY, Pitney M, Jepson N. The ESHC-BVS Registry – 5 Year Outcomes With the Bioresorbable Vascular Scaffold [abstract] Heart Lung Circ. 2022 Jan;3:S2357.
Gallagher S, Anderson RA. Lives cases from the University Hospital of Wales. Orbital atherectomy in complex coronary disease. Back LM. Case and media assistant. British Cardiovascular Intervention Society (BCIS) Advanced Cardiac Interventions conference (ACI) April 2022. London, UK.
2020
Magdy J, Kennedy M, Back LM, Pitney M. Outcomes of the first 5 years of the Sutherland Heart Clinic Chest Pain Clinic (CPC). Heart Lung Circ. 2020 Nov;29(2):s272.
2019
Back LM, Indraratna P, Kushwaha V. Early Results of the Prince of Wales Hospital Rapid Access Cardiology Clinic (RACC). Heart Lung Circ. 2019 Jan;28(4):s295.
2018
McGrath J, Guiney L, Li J, Vickers D, Mikhail P, Yu J, Blake V, Robaei D, Back LM, Ooi, SY, Pitney M, Jepson N. Long-Term Clinical Outcomes Following Implantation of Bioresorbable Vascular Scaffolds: Experience from Two Australian Centres. Heart Lung Circ. 2018 Jan; S459-460.
2016
Robaei D, Foin N, Back LM, Spies M, Kushwaha V, Ooi S-Y, Pitney M, Jepson N. Bifurcational coronary lesions treated with everolimus-eluting BRS: procedural strategies and clinical outcomes [abstract]. In: Book of abstracts of the EuroPCR conference 2016, May 17-20; Paris, France. Abstract 59.
Robaei D, Spies M, Back LM, Kushwaha V, Ooi S-Y, Giles R, Pitney M, Jepson N. (2016) Two Year Outcomes Of An Everolimus-Eluting BRS In Real-World Coronary Artery Disease [abstract]. In: Book of abstract of the EuroPCR conference; 2016, May 17-20; Paris, France. Abstract 60.2015
Robaei D, Back LM, Ooi SY, Pitney MR, Jepson N. Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day outcomes at two Australian Centres. Heart Lung Circ. 2015 Feb; S1442-9506.
Robaei D, Back LM, Atique S, Tan R, Ooi SY, Giles R, Farshid A, Pitney M, Jepson N. Australian multicentre experience with bioresorbable vascular scaffolds in “real-world” coronary disease - twelvemonth outcomes. Heart Lung Circ. 2015 Jun; S263.
2014
Robaei D, Back LM, Ooi S.Y, Pitney M, Jepson N. Procedural and 30-day outcomes with use of bioresorbable scaffolds in real-world disease, including complex coronary artery disease. [abstract]. In: Book of abstract of the EuroPCR conference; 2014, May 20-23; Paris, France.
Robaei D, Back LM, Ooi S.Y, Pitney M, Jepson N. Overlapping of bioresorbable scaffolds – Early experience at two Australian centres. [abstract]. In: Book of abstract of the EuroPCR conference; 2014, May 20-23; Paris, France.
Nguyen M, Jepson N, Chia Y, Yau P, Pitney M, Whelan A, Back LM, Hendricks R, Ooi SY, Kanna R, Ahmadi A. PM200 Australian Experience with AbsorbTM Bioresorbable Scaffold Technology in “Real World” Coronary Disease. 2014, Mar;9(1):e104.
2013
Jepson N, Arnott C, Back LM, Ooi, SY, Pitney M. Real-World Experience with Absorb™ Bioresorbable Scaffold Technology – Early Australian Registry Results. [abstract] In: J Am Coll Cardiol. 2013;62(18):B131B132.